MSF South Asia 100d ago

Aung Thura, a 20‑year‑old from Hpakant, Kachin State, successfully completed treatment for drug‑resistant TB in 2024, despite intense conflict and the personal loss of his father to the same disease. His story highlights both what is possible and what is increasingly at risk in Myanmar, where conflict, supply limitations, staff shortages, and service disruptions are driving a sharp decline in TB treatment access. With fewer than a quarter of estimated MDR‑TB patients initiated on treatment in 2024, success stories like Aung Thura’s are increasingly under threat unless urgent action is taken to restore access to care and medical supplies.